The role of COX-2 inhibitors in pain modulationCAMU, Frederic; LIN SHI; VANLERSBERGHE, Caroline et al.Drugs (Basel). 2003, Vol 63, pp 1-7, issn 0012-6667, 7 p., SUP1Conference Paper

SAR: Flavonoids and COX-2 inhibitionROSENKRANZ, Herbert S; THAMPATTY, Bhavani P.Oncology research. 2003, Vol 13, Num 12, pp 529-535, issn 0965-0407, 7 p.Article

Anti-inflammatory action of legume isoflavonoid sophoricoside through inhibition on cyclooxygenase-2 activityBYUNG HAK KIM; EUN YONG CHUNG; MIN, Bo-Kyung et al.Planta medica. 2003, Vol 69, Num 5, pp 474-476, issn 0032-0943, 3 p.Article

Oral bioavailability and pharmacokinetics of DRF-4367, a new cox-2 inhibitor in ratsRAMESH, Mullangi; MAMIDI, Rao N. V. S; JAGANNATH, Kota et al.European journal of drug metabolism and pharmacokinetics. 2003, Vol 28, Num 2, pp 137-141, issn 0378-7966, 5 p.Article

Inhibitory effects of furanocoumarins isolated from the roots of Angelica dahurica on prostaglandin E₂ productionHYUN SEUNG BAN; SOON SUNG LIM; SUZUKI, Katsuya et al.Planta medica. 2003, Vol 69, Num 5, pp 408-412, issn 0032-0943, 5 p.Article

Rofecoxib and early relapse of inflammatory bowel disease: an open-label trialBIANCORNE, L; TOSTI, C; GEREMIA, A et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 7, pp 755-764, issn 0269-2813, 10 p.Article

The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticariaBOEHNCKE, W-H; LUDWIG, R. J; ZOLLNER, T. M et al.British journal of dermatology (1951). 2003, Vol 148, Num 3, pp 604-606, issn 0007-0963, 3 p.Article

Outcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefitsGOMEZ CEREZO, Jorge; LUBOMIROV HRISTOV, Rubin; CARCAS SANSUAN, Antonio J et al.European journal of clinical pharmacology. 2003, Vol 59, Num 2, pp 169-175, issn 0031-6970, 7 p.Article

Pinolenic acid inhibits human breast cancer MDA-MB-231 cell metastasis in vitroCHEN, Szu-Jung; HSU, Chih-Ping; LI, Chi-Wei et al.Food chemistry. 2011, Vol 126, Num 4, pp 1708-1715, issn 0308-8146, 8 p.Article

Therapeutic perspectives and strategies for obtaining new NSAIDsCUELLAR RODRIGUEZ, S.Methods and findings in experimental and clinical pharmacology. 2000, Vol 22, Num 6, pp 363-364, issn 0379-0355Conference Paper

Isoenzymes de la cyclooxygénase : rôle physiologique et pharmacologie = Cyclo-oxygenase isoenzymes : physiology and pharmacologyHABERER, J.-P.Cahiers d'anesthésiologie (Paris). 2000, Vol 48, Num 4, pp 289-294, issn 0007-9685Article

Cyclooxygenase-2 expression in human pancreatic adenocarcinomasYIP-SCHNEIDER, M. T; BARNARD, D. S; BILLINGS, S. D et al.Carcinogenesis (New York. Print). 2000, Vol 21, Num 2, pp 139-146, issn 0143-3334Article

The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E₂ synthesisMINTER, Helena A; EVESON, John W; HUNTLEY, Suzanne et al.Clinical cancer research. 2003, Vol 9, Num 5, pp 1885-1897, issn 1078-0432, 13 p.Article

Serum proteomic profiles suggest celecoxib-modulated targets and response predictorsZHEN XIAO; LUKE, Brian T; HAWK, Ernest T et al.Cancer research (Baltimore). 2004, Vol 64, Num 8, pp 2904-2909, issn 0008-5472, 6 p.Article

Syndrome d'hypersensibilité au célécoxib = Hypersensivity to celecoxibFRADET, Gérard; ROBIN-LE NECHET, Anne; HUGUENTN, Hélène et al.Annales de médecine interne (Paris). 2003, Vol 154, Num 3, pp 181-182, issn 0003-410X, 2 p.Article

Proceedings from the roundtable on the role of coxibs in successful pain management, August 17-18, 2001, New York, NY, USAPAYNE, Richard.Journal of pain and symptom management. 2002, Vol 24, Num 1, issn 0885-3924, 49 p., SUPConference Proceedings

Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and diseaseRAISZ, Lawrence G.The American journal of medicine. 2001, Vol 110, Num 3A, pp 43S-45S, issn 0002-9343Article

Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of post-operative dental painKELLSTEIN, D; OTT, D; JAYAWARDENE, S et al.International journal of clinical practice (Esher). 2004, Vol 58, Num 3, pp 244-250, issn 1368-5031, 7 p.Article

Celecoxib but not rofecoxib inhibits the growth of transformed cells in vitroKAZANOV, Diana; DVORY-SOBOL, Hadas; PICK, Marjorie et al.Clinical cancer research. 2004, Vol 10, Num 1, pp 267-271, issn 1078-0432, 5 p., 1Article

Rofecoxib-β-cyclodextrin inclusion complex for solubility enhancementRAWAT, S; JAIN, S. K.Pharmazie. 2003, Vol 58, Num 9, pp 639-641, issn 0031-7144, 3 p.Article

Determination of celecoxib, a COX-2 inhibitor, in pharmaceutical dosage forms by MEKCSRINIVASU, M. K; SREENIVAS RAO, D; OM REDDY, G et al.Journal of pharmaceutical and biomedical analysis. 2002, Vol 28, Num 3-4, pp 493-500, issn 0731-7085Article

Pain management and beyond: Evolving concepts and treatments involving cyclooxygenase inhibitionSTAATS, Peter S.Journal of pain and symptom management. 2002, Vol 24, Num 1, pp S4-S9, issn 0885-3924, SUPConference Paper

Les inhibiteurs de COX-1 et COX-2, données cliniques : quelles alertes possibles en pharmacovigilance ? = Clinical data with COX-1 and COX-2 inhibitors : what possible alerts in pharmacovigilance?LAROUSSE, C; VEYRAC, G.Thérapie (Paris). 2000, Vol 55, Num 1, pp 21-28, issn 0040-5957Conference Paper

Une nouvelle génération d'anti-inflammatoires non stéroïdiens = A new generation of non steroid antiinflammation drugsJOUZEAU, Jean-Yves; TERLAIN, Bernard.MT. Médecine thérapeutique. 2000, Vol 6, Num 8, pp 669-674, issn 1264-6520Article

Perioperative rofecoxib improves early recovery after outpatient herniorrhaphyHONG MA; JUN TANG; CARROLL, Brendan J et al.Anesthesia and analgesia. 2004, Vol 98, Num 4, pp 970-975, issn 0003-2999, 6 p.Article